<DOC>
	<DOC>NCT02332044</DOC>
	<brief_summary>The purpose of this study is to evaluate the drug-drug interaction between Erdosteine and Bepotastine besilate in healthy adult volunteers.</brief_summary>
	<brief_title>Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Erdosteine</mesh_term>
	<criteria>Healthy male subjects aged 20 45 years A body mass index in the range 18.5 25 kg/m2 Willingness to participate during the entire study period Written informed consent after being fully informed about the study procedures Any past medical history of hepatic, renal, gastrointestinal, respiratory, endocrine, psychiatric, neurologic, haematooncologic or cardiovascular disease History of clinically significant drug hypersensitivity Use of medication within 7 days before the first dose Heavy drinker/smoker Whole blood donation during 60 days before the study Judged not eligible for study participation by investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>